POROK3
MCID: PRK080
MIFTS: 25

Porokeratosis 3, Multiple Types (POROK3)

Categories: Cancer diseases, Genetic diseases, Rare diseases, Skin diseases

Aliases & Classifications for Porokeratosis 3, Multiple Types

MalaCards integrated aliases for Porokeratosis 3, Multiple Types:

Name: Porokeratosis 3, Multiple Types 58 76
Porokeratosis, Disseminated Superficial Actinic, 1 58 76 74
Porokeratosis, Disseminated Superficial Actinic 1 54 30 6
Dsap1 58 54 76
Porok3 58 76
Porokeratosis, Disseminated Superficial Actinic, 1; Dsap1 58
Porokeratosis 3, Disseminated Superficial Actinic Type 76
Porokeratosis 3, Disseminated Superficial Actinic 13
Disseminated Superficial Actinic Porokeratosis 1 76
Porokeratosis, Type 3, Multiple Types ) 41

Characteristics:

OMIM:

58
Inheritance:
autosomal dominant

Miscellaneous:
intrafamilial variability
onset of lesions usually in first through fourth decades of life, but may occur as late as the seventh decade


HPO:

33
porokeratosis 3, multiple types:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 58 175900
MeSH 45 D017499
MedGen 43 C1867981
UMLS 74 C1867981

Summaries for Porokeratosis 3, Multiple Types

OMIM : 58 Porokeratosis is a rare skin disorder characterized by one or more annular plaques with a surrounding raised horny border that spreads centrifugally. Variants of porokeratosis have been described that differ in morphologic shapes, distribution, and clinical course (Schamroth et al., 1997). However, as noted by Sybert (2010), several families with expression of more than one variant of porokeratosis among members, and individuals expressing more than one variant, have been reported, suggesting that the distinctions among these variants may be artificial. Mutations in the MVK gene have been found to cause multiple types of porokeratosis, which have been described as disseminated superficial actinic porokeratosis (DSAP), nonactinic disseminated superficial porokeratosis (DSP), porokeratosis of Mibelli, giant plaque of porokeratosis ptychotropica, hyperkeratotic porokeratosis, and linear porokeratosis. The preferred title of this entry was formerly 'Porokeratosis 3, Disseminated Superficial Actinic Type; POROK3.' Disseminated superficial actinic porokeratosis is the most common subtype of porokeratosis. It is characterized by multiple small, annular, anhidrotic, keratotic lesions that are located predominantly on sun-exposed areas of the skin, such as the face, neck, and distal limbs. The lesions typically begin to develop in adolescence and reach near-complete penetrance by the third or fourth decade of life (summary by Wu et al., 2004 and Zhang et al., 2012). For a discussion of genetic heterogeneity of porokeratosis, see 175800. (175900)

MalaCards based summary : Porokeratosis 3, Multiple Types, also known as porokeratosis, disseminated superficial actinic, 1, is related to porokeratosis. An important gene associated with Porokeratosis 3, Multiple Types is MVK (Mevalonate Kinase). Affiliated tissues include skin, and related phenotypes are nail dystrophy and parakeratosis

UniProtKB/Swiss-Prot : 76 Porokeratosis 3, multiple types: A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Different clinical presentations can be observed among members of the same family. Individuals expressing more than one variant have also been reported.

Related Diseases for Porokeratosis 3, Multiple Types

Diseases in the Porokeratosis family:

Porokeratosis 1, Multiple Types Porokeratosis 3, Multiple Types
Porokeratosis 6, Multiple Types Porokeratosis 7, Multiple Types
Porokeratosis 9, Multiple Types

Diseases related to Porokeratosis 3, Multiple Types via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 porokeratosis 11.6

Symptoms & Phenotypes for Porokeratosis 3, Multiple Types

Human phenotypes related to Porokeratosis 3, Multiple Types:

33
# Description HPO Frequency HPO Source Accession
1 nail dystrophy 33 occasional (7.5%) HP:0008404
2 parakeratosis 33 HP:0001036
3 porokeratosis 33 HP:0200044

Symptoms via clinical synopsis from OMIM:

58
Skin Nails Hair Skin:
porokeratosis of mibelli
hyperkeratotic porokeratosis
small, annular, anhidrotic keratotic lesions located predominantly on sun-exposed areas
central atrophic area with peripheral keratotic ridge
disseminated superficial actinic porokeratosis
more
Skin Nails Hair Nails:
nail dystrophy (in some patients)

Skin Nails Hair Skin Histology:
epidermal atrophy
vertical columns of parakeratosis (cornoid lamella) overlying absent or reduced granular layer with dyskeratotic cells
nonspecific perivascular infiltrate of chronic inflammatory cells

Clinical features from OMIM:

175900

Drugs & Therapeutics for Porokeratosis 3, Multiple Types

Search Clinical Trials , NIH Clinical Center for Porokeratosis 3, Multiple Types

Genetic Tests for Porokeratosis 3, Multiple Types

Genetic tests related to Porokeratosis 3, Multiple Types:

# Genetic test Affiliating Genes
1 Porokeratosis, Disseminated Superficial Actinic 1 30 MVK

Anatomical Context for Porokeratosis 3, Multiple Types

MalaCards organs/tissues related to Porokeratosis 3, Multiple Types:

42
Skin

Publications for Porokeratosis 3, Multiple Types

Articles related to Porokeratosis 3, Multiple Types:

# Title Authors Year
1
Genomic variations of the mevalonate pathway in porokeratosis. ( 26202976 )
2015
2
Splicing mutation in MVK is a cause of porokeratosis of Mibelli. ( 24781643 )
2014
3
Updating and correcting the description of MVK mutations identified in Chinese patients with disseminated superficial actinic porokeratosis. ( 24794831 )
2014
4
Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis. ( 22983302 )
2012
5
Loss of heterozygosity studies on chromosome 12q in disseminated superficial actinic porokeratosis: lessons to be learned. ( 17392836 )
2007
6
Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. ( 16835861 )
2006
7
A mutation in SART3 gene in a Chinese pedigree with disseminated superficial actinic porokeratosis. ( 15840095 )
2005
8
Confirmation and refinement of a genetic locus for disseminated superficial actinic porokeratosis (DSAP1) at 12q23.2-24.1. ( 15149516 )
2004
9
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. ( 11313769 )
2001

Variations for Porokeratosis 3, Multiple Types

UniProtKB/Swiss-Prot genetic disease variations for Porokeratosis 3, Multiple Types:

76
# Symbol AA change Variation ID SNP ID
1 MVK p.Gly202Arg VAR_010962 rs104895301
2 MVK p.Gly12Arg VAR_075036
3 MVK p.Leu41Pro VAR_075037 rs397514571
4 MVK p.Leu255Pro VAR_075038 rs397514570
5 MVK p.Leu279Pro VAR_075039
6 MVK p.Tyr291Asp VAR_075040
7 MVK p.His312Arg VAR_075041
8 MVK p.Phe365Ser VAR_075042 rs398122911
9 MVK p.Gly376Ser VAR_075043 rs971159663

ClinVar genetic disease variations for Porokeratosis 3, Multiple Types:

6 (show top 50) (show all 76)
# Gene Variation Type Significance SNP ID Assembly Location
1 SART3 NM_014706.4(SART3): c.1771G> A (p.Val591Met) single nucleotide variant Uncertain significance rs118203954 GRCh37 Chromosome 12, 108924063: 108924063
2 SART3 NM_014706.4(SART3): c.1771G> A (p.Val591Met) single nucleotide variant Uncertain significance rs118203954 GRCh38 Chromosome 12, 108530286: 108530286
3 MVK NM_000431.3(MVK): c.1129G> A (p.Val377Ile) single nucleotide variant Pathogenic rs28934897 GRCh37 Chromosome 12, 110034320: 110034320
4 MVK NM_000431.3(MVK): c.1129G> A (p.Val377Ile) single nucleotide variant Pathogenic rs28934897 GRCh38 Chromosome 12, 109596515: 109596515
5 MVK NM_000431.3(MVK): c.1000G> A (p.Ala334Thr) single nucleotide variant Pathogenic rs104895317 GRCh37 Chromosome 12, 110032947: 110032947
6 MVK NM_000431.3(MVK): c.1000G> A (p.Ala334Thr) single nucleotide variant Pathogenic rs104895317 GRCh38 Chromosome 12, 109595142: 109595142
7 MVK NM_000431.3(MVK): c.803T> C (p.Ile268Thr) single nucleotide variant Pathogenic rs104895304 GRCh37 Chromosome 12, 110029080: 110029080
8 MVK NM_000431.3(MVK): c.803T> C (p.Ile268Thr) single nucleotide variant Pathogenic rs104895304 GRCh38 Chromosome 12, 109591275: 109591275
9 MVK NM_000431.3(MVK): c.928G> A (p.Val310Met) single nucleotide variant Pathogenic rs104895319 GRCh37 Chromosome 12, 110032875: 110032875
10 MVK NM_000431.3(MVK): c.928G> A (p.Val310Met) single nucleotide variant Pathogenic rs104895319 GRCh38 Chromosome 12, 109595070: 109595070
11 MVK NM_000431.3(MVK): c.764T> C (p.Leu255Pro) single nucleotide variant Pathogenic rs397514570 GRCh37 Chromosome 12, 110028662: 110028662
12 MVK NM_000431.3(MVK): c.764T> C (p.Leu255Pro) single nucleotide variant Pathogenic rs397514570 GRCh38 Chromosome 12, 109590857: 109590857
13 MVK NM_000431.3(MVK): c.604G> A (p.Gly202Arg) single nucleotide variant Pathogenic rs104895301 GRCh37 Chromosome 12, 110023903: 110023903
14 MVK NM_000431.3(MVK): c.604G> A (p.Gly202Arg) single nucleotide variant Pathogenic rs104895301 GRCh38 Chromosome 12, 109586098: 109586098
15 MVK NM_000431.3(MVK): c.417dupC (p.Gly140Argfs) duplication Pathogenic rs104895373 GRCh37 Chromosome 12, 110019245: 110019245
16 MVK NM_000431.3(MVK): c.417dupC (p.Gly140Argfs) duplication Pathogenic rs104895373 GRCh38 Chromosome 12, 109581440: 109581440
17 MVK NM_000431.3(MVK): c.122T> C (p.Leu41Pro) single nucleotide variant Pathogenic rs397514571 GRCh37 Chromosome 12, 110013846: 110013846
18 MVK NM_000431.3(MVK): c.122T> C (p.Leu41Pro) single nucleotide variant Pathogenic rs397514571 GRCh38 Chromosome 12, 109576041: 109576041
19 MVK NM_000431.3(MVK): c.1039+2T> C single nucleotide variant Pathogenic rs398122910 GRCh37 Chromosome 12, 110032988: 110032988
20 MVK NM_000431.3(MVK): c.1039+2T> C single nucleotide variant Pathogenic rs398122910 GRCh38 Chromosome 12, 109595183: 109595183
21 MVK NM_000431.3(MVK): c.1094T> C (p.Phe365Ser) single nucleotide variant Pathogenic rs398122911 GRCh37 Chromosome 12, 110034285: 110034285
22 MVK NM_000431.3(MVK): c.1094T> C (p.Phe365Ser) single nucleotide variant Pathogenic rs398122911 GRCh38 Chromosome 12, 109596480: 109596480
23 MVK NM_000431.3(MVK): c.1005C> T (p.Gly335=) single nucleotide variant Conflicting interpretations of pathogenicity rs104895357 GRCh37 Chromosome 12, 110032952: 110032952
24 MVK NM_000431.3(MVK): c.1005C> T (p.Gly335=) single nucleotide variant Conflicting interpretations of pathogenicity rs104895357 GRCh38 Chromosome 12, 109595147: 109595147
25 MVK NM_000431.3(MVK): c.1067C> T (p.Thr356Met) single nucleotide variant Uncertain significance rs104895342 GRCh37 Chromosome 12, 110034258: 110034258
26 MVK NM_000431.3(MVK): c.1067C> T (p.Thr356Met) single nucleotide variant Uncertain significance rs104895342 GRCh38 Chromosome 12, 109596453: 109596453
27 MVK NM_000431.3(MVK): c.1139A> G (p.His380Arg) single nucleotide variant Conflicting interpretations of pathogenicity rs104895324 GRCh37 Chromosome 12, 110034330: 110034330
28 MVK NM_000431.3(MVK): c.1139A> G (p.His380Arg) single nucleotide variant Conflicting interpretations of pathogenicity rs104895324 GRCh38 Chromosome 12, 109596525: 109596525
29 MVK NM_000431.3(MVK): c.238G> A (p.Val80Ile) single nucleotide variant Conflicting interpretations of pathogenicity rs76914224 GRCh37 Chromosome 12, 110017618: 110017618
30 MVK NM_000431.3(MVK): c.238G> A (p.Val80Ile) single nucleotide variant Conflicting interpretations of pathogenicity rs76914224 GRCh38 Chromosome 12, 109579813: 109579813
31 MVK NM_000431.3(MVK): c.405G> A (p.Ser135=) single nucleotide variant Benign/Likely benign rs34368092 GRCh37 Chromosome 12, 110019233: 110019233
32 MVK NM_000431.3(MVK): c.405G> A (p.Ser135=) single nucleotide variant Benign/Likely benign rs34368092 GRCh38 Chromosome 12, 109581428: 109581428
33 MVK NM_000431.3(MVK): c.441C> T (p.Ala147=) single nucleotide variant Conflicting interpretations of pathogenicity rs138342076 GRCh38 Chromosome 12, 109581464: 109581464
34 MVK NM_000431.3(MVK): c.924C> T (p.Leu308=) single nucleotide variant Conflicting interpretations of pathogenicity rs72648042 GRCh37 Chromosome 12, 110032871: 110032871
35 MVK NM_000431.3(MVK): c.924C> T (p.Leu308=) single nucleotide variant Conflicting interpretations of pathogenicity rs72648042 GRCh38 Chromosome 12, 109595066: 109595066
36 MVK NM_000431.3(MVK): c.226+4A> G single nucleotide variant Conflicting interpretations of pathogenicity rs145732290 GRCh37 Chromosome 12, 110013954: 110013954
37 MVK NM_000431.3(MVK): c.226+4A> G single nucleotide variant Conflicting interpretations of pathogenicity rs145732290 GRCh38 Chromosome 12, 109576149: 109576149
38 MVK NM_000431.3(MVK): c.780C> A (p.Ile260=) single nucleotide variant Conflicting interpretations of pathogenicity rs34975996 GRCh38 Chromosome 12, 109591252: 109591252
39 MVK NM_000431.3(MVK): c.780C> A (p.Ile260=) single nucleotide variant Conflicting interpretations of pathogenicity rs34975996 GRCh37 Chromosome 12, 110029057: 110029057
40 MVK NM_000431.3(MVK): c.1039+8G> C single nucleotide variant Likely benign rs765989100 GRCh37 Chromosome 12, 110032994: 110032994
41 MVK NM_000431.3(MVK): c.1039+8G> C single nucleotide variant Likely benign rs765989100 GRCh38 Chromosome 12, 109595189: 109595189
42 MVK NM_000431.3(MVK): c.618T> A (p.Ala206=) single nucleotide variant Likely benign rs370745426 GRCh37 Chromosome 12, 110023917: 110023917
43 MVK NM_000431.3(MVK): c.618T> A (p.Ala206=) single nucleotide variant Likely benign rs370745426 GRCh38 Chromosome 12, 109586112: 109586112
44 MVK NM_000431.3(MVK): c.864G> A (p.Pro288=) single nucleotide variant Likely benign rs149708247 GRCh38 Chromosome 12, 109591336: 109591336
45 MVK NM_000431.3(MVK): c.864G> A (p.Pro288=) single nucleotide variant Likely benign rs149708247 GRCh37 Chromosome 12, 110029141: 110029141
46 MVK NM_000431.3(MVK): c.975C> T (p.Arg325=) single nucleotide variant Likely benign rs748947620 GRCh37 Chromosome 12, 110032922: 110032922
47 MVK NM_000431.3(MVK): c.975C> T (p.Arg325=) single nucleotide variant Likely benign rs748947620 GRCh38 Chromosome 12, 109595117: 109595117
48 MVK NM_000431.3(MVK): c.545T> A (p.Leu182Ter) single nucleotide variant Pathogenic GRCh37 Chromosome 12, 110023844: 110023844
49 MVK NM_000431.3(MVK): c.545T> A (p.Leu182Ter) single nucleotide variant Pathogenic GRCh38 Chromosome 12, 109586039: 109586039
50 MVK NM_000431.3(MVK): c.1096G> C (p.Asp366His) single nucleotide variant Uncertain significance GRCh37 Chromosome 12, 110034287: 110034287

Cosmic variations for Porokeratosis 3, Multiple Types:

9 (show top 50) (show all 361)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM44097 TP53 skin,face,carcinoma,NS c.530C>T p.P177L 17:7675082-7675082 0
2 COSM10705 TP53 skin,face,carcinoma,squamous cell carcinoma c.586C>T p.R196* 17:7674945-7674945 0
3 COSM44295 TP53 skin,face,carcinoma,NS c.993+1G>A p.? 17:7673534-7673534 0
4 COSM10939 TP53 skin,face,carcinoma,NS c.832C>T p.P278S 17:7673788-7673788 0
5 COSM43544 TP53 skin,face,carcinoma,squamous cell carcinoma c.260C>A p.P87Q 17:7676109-7676109 0
6 COSM44326 TP53 skin,face,carcinoma,squamous cell carcinoma c.706T>C p.Y236H 17:7674257-7674257 0
7 COSM10662 TP53 skin,face,carcinoma,NS c.743G>A p.R248Q 17:7674220-7674220 0
8 COSM11449 TP53 skin,face,carcinoma,NS c.388C>T p.L130F 17:7675224-7675224 0
9 COSM44068 TP53 skin,face,carcinoma,NS c.532C>A p.H178N 17:7675080-7675080 0
10 COSM10654 TP53 skin,face,carcinoma,NS c.637C>T p.R213* 17:7674894-7674894 0
11 COSM10656 TP53 skin,face,carcinoma,squamous cell carcinoma c.742C>T p.R248W 17:7674221-7674221 0
12 COSM45830 TP53 skin,face,carcinoma,squamous cell carcinoma c.766A>C p.T256P 17:7674197-7674197 0
13 COSM10812 TP53 skin,face,carcinoma,NS c.722C>T p.S241F 17:7674241-7674241 0
14 COSM10726 TP53 skin,face,carcinoma,NS c.856G>A p.E286K 17:7673764-7673764 0
15 COSM10992 TP53 skin,face,carcinoma,NS c.844C>G p.R282G 17:7673776-7673776 0
16 COSM45304 TP53 skin,face,carcinoma,squamous cell carcinoma c.375+1G>A p.? 17:7675993-7675993 0
17 COSM43588 TP53 skin,face,carcinoma,squamous cell carcinoma c.740A>C p.N247T 17:7674223-7674223 0
18 COSM11081 TP53 skin,face,carcinoma,squamous cell carcinoma c.733G>T p.G245C 17:7674230-7674230 0
19 COSM11073 TP53 skin,face,carcinoma,NS c.1024C>T p.R342* 17:7670685-7670685 0
20 COSM43582 TP53 skin,face,carcinoma,NS c.454C>T p.P152S 17:7675158-7675158 0
21 COSM45733 TP53 skin,face,carcinoma,NS c.432G>A p.Q144Q 17:7675180-7675180 0
22 COSM10704 TP53 skin,face,carcinoma,NS c.844C>T p.R282W 17:7673776-7673776 0
23 COSM43700 TP53 skin,face,carcinoma,NS c.712T>A p.C238S 17:7674251-7674251 0
24 COSM10733 TP53 skin,face,carcinoma,squamous cell carcinoma c.574C>T p.Q192* 17:7674957-7674957 0
25 COSM44227 TP53 skin,face,carcinoma,NS c.854A>T p.E285V 17:7673766-7673766 0
26 COSM10768 TP53 skin,face,carcinoma,NS c.535C>T p.H179Y 17:7675077-7675077 0
27 COSM43651 TP53 skin,face,carcinoma,squamous cell carcinoma c.763A>T p.I255F 17:7674200-7674200 0
28 COSM44435 TP53 skin,face,carcinoma,NS c.96+1G>A p.? 17:7676381-7676381 0
29 COSM43920 TP53 skin,face,carcinoma,NS c.680C>T p.S227F 17:7674283-7674283 0
30 COSM44436 TP53 skin,face,carcinoma,NS c.375+2T>C p.? 17:7675992-7675992 0
31 COSM43596 TP53 skin,face,carcinoma,NS c.841G>A p.D281N 17:7673779-7673779 0
32 COSM10749 TP53 skin,face,carcinoma,NS c.830G>T p.C277F 17:7673790-7673790 0
33 COSM11084 TP53 skin,face,carcinoma,NS c.517G>A p.V173M 17:7675095-7675095 0
34 COSM43742 TP53 skin,face,carcinoma,NS c.419C>T p.T140I 17:7675193-7675193 0
35 COSM10887 TP53 skin,face,carcinoma,NS c.833C>G p.P278R 17:7673787-7673787 0
36 COSM44241 TP53 skin,face,carcinoma,NS c.592G>T p.E198* 17:7674939-7674939 0
37 COSM43665 TP53 skin,face,carcinoma,squamous cell carcinoma c.746G>C p.R249T 17:7674217-7674217 0
38 COSM10728 TP53 skin,face,carcinoma,NS c.839G>A p.R280K 17:7673781-7673781 0
39 COSM10988 TP53 skin,face,carcinoma,squamous cell carcinoma c.772G>A p.E258K 17:7674191-7674191 0
40 COSM45677 TP53 skin,face,carcinoma,squamous cell carcinoma c.714T>A p.C238* 17:7674249-7674249 0
41 COSM44552 TP53 skin,face,carcinoma,NS c.509C>T p.T170M 17:7675103-7675103 0
42 COSM607136 TGFBR1 skin,neck,carcinoma,squamous cell carcinoma c.1247C>T p.S416F 9:99146601-99146601 0
43 COSM13233 SUFU skin,face,carcinoma,NS c.591C>T p.F197F 10:102592718-102592718 0
44 COSM13234 SUFU skin,face,carcinoma,NS c.560C>T p.P187L 10:102592687-102592687 0
45 COSM3942016 SMO skin,face,carcinoma,NS c.1376C>T p.A459V 7:129209307-129209307 0
46 COSM13145 SMO skin,face,carcinoma,NS c.595C>T p.R199W 7:129205260-129205260 0
47 COSM216037 SMO skin,face,carcinoma,NS c.1234C>T p.L412F 7:129206557-129206557 0
48 COSM13146 SMO skin,face,carcinoma,NS c.1604G>T p.W535L 7:129210500-129210500 0
49 COSM6962965 SMO skin,neck,carcinoma,squamous cell carcinoma c.1103C>T p.P368L 7:129206332-129206332 0
50 COSM13144 SMO skin,face,carcinoma,NS c.1598G>A p.S533N 7:129210494-129210494 0

Expression for Porokeratosis 3, Multiple Types

Search GEO for disease gene expression data for Porokeratosis 3, Multiple Types.

Pathways for Porokeratosis 3, Multiple Types

GO Terms for Porokeratosis 3, Multiple Types

Sources for Porokeratosis 3, Multiple Types

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....